Revision treatment for recurrent nasal obstruction shows effectiveness, suggesting careful patient selection for best results.
Revision RFA is a safe and effective treatment option for selected patients with recurrent nasal obstruction due to ITH. Higher revision rates were observed in older patients and those with medical comorbidities and rhinitis medicamentosa. Revision RFA should be considered as a conservative second-line treatment in appropriately selected patients.
No takes yet. Share an insight, caveat, or question.
Carmel-Neiderman et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: